lobbying_activities: 3140328
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3140328 | e81fc11e-962e-4486-9b74-81d6ce0adcbe | Q1 | RED+BLUE STRATEGIES | 400693064 | CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) | 2024 | first_quarter | MMM | H.R. 4366 - Consolidated Appropriations Act of FY 2024 - Issues related to health care policy provisions included in the bill writ large. H.R. 2882 - Further Consolidated Appropriations Act of FY 2024 - Issues related to funding of the Department of Health and Human Services and agencies focused on Medicare, Medicaid and other health care programs. S. 3430 Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023- Issues related to supporting health plans that are working to ensure that there are tools available to provide access to mental health care for families as well as ensuring that tools used to keep prices of prescription medication affordable. H.R. 3561 - The PATIENT Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. H.R. 5378 - Lower Costs, More Transparency Act of 2023 - Issues related to plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. S. 2973 - Modernizing and Ensuring PBM Accountability Act of 2023 - Issues related to Plans and PBMs and their ability to successfully support the national goal of bringing down the cost of prescription medications in the Medicare program. Issues related to the successful implementation of the Inflation Reduction Act with a focus on lowering prescription medication prices in the Medicare program and ensuring affordable coverage options in the Marketplaces. HHS and CMS Rules and Regulations focused on the Medicare Advantage program including: CY 2024 Rate Announcement, CY 2024 Medicare Advantage technical rules. Issues related improving outcomes and access in mental and behavioral health in Medicare, Medicaid and the Marketplaces. Issues related to developing coherent prior authorization methodologies. Issues related to the Public Health Emergency and the impact that unwinding will have on individuals access to quality, affordable health care coverage in Medicaid and the Marketplaces. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2024-04-07T17:11:23-04:00 |